⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5654823 | 0.95 | — | — | |
| SCHEMBL5653288 | 0.90 | — | — | |
| SCHEMBL5652423 | 0.84 | — | — | |
| SCHEMBL5653796 | 0.84 | — | — | |
| SCHEMBL5650882 | 0.82 | ADORA2A (0.47) | — | |
| SCHEMBL5653934 | 0.82 | ADORA2A (0.55) | — | |
| SCHEMBL5109127 | 0.81 | — | — | |
| SCHEMBL5413479 | 0.78 | — | — | |
| SCHEMBL5652917 | 0.78 | — | — | |
| SCHEMBL5413272 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070010522-A1 | Triazolo[1,5-c]pyrimidines and pyrazolo[1,5-c]pyrimidines useful as a2a adenosine receptor antagonists | BIOGEN IDEC MA INC. | 2007-01-11 | — | — | US | claimed |
| US-20070010522-A1 | Triazolo[1,5-c]pyrimidines and pyrazolo[1,5-c]pyrimidines useful as a2a adenosine receptor antagonists | BIOGEN IDEC MA INC. | 2007-01-11 | — | — | US | disclosed |